Lipocine Inc (LPCN)
4.86
+0.02
(+0.41%)
USD |
NASDAQ |
Dec 23, 11:13
Lipocine Market Cap: 25.99M for Dec. 23, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 149.18B |
Reviva Pharmaceuticals Holdings Inc | 43.14M |
NovaBay Pharmaceuticals Inc | 2.401M |
Palatin Technologies Inc | 20.53M |
iBio Inc | 21.78M |
Market Cap Related Metrics
PS Ratio | 5.407 |
Price to Book Value | 1.360 |
Price | 4.86 |
Earnings Yield | -15.84% |